Literature DB >> 11936835

alpha-Crystallin chaperone function in diabetic rat and human lenses.

Prajitha Thampi1, Shamshad Zarina, Edathara C Abraham.   

Abstract

This study focussed on the effect of diabetes on the chaperone function of alpha-crystallin. The authors relied on diabetic rats with a wide range of plasma glucose levels and non-diabetic control rats to establish a possible relationship between severity of diabetes and alpha-crystallin chaperone activity. In addition, 52-56 and 63-69 year-old diabetic and non-diabetic human lenses were used to show whether diabetes affects alpha-crystallin chaperone activity in human lenses. Correlation between plasma glucose levels and loss of chaperone activity of the alphaL-crystallin fraction in diabetic rats indicated good correlation. The glycemic threshold, reported before for cataract development in diabetic rats, seems to be valid for the chaperone activity loss as well. Analysis of the human lens alphaL-crystallin showed lower chaperone activity in all the diabetic lenses than in the age-matched control lenses. In the 63-69 age group, the loss in chaperone activity due to diabetes was significantly larger than in the 52-56 age group suggesting a dominant effect of duration of diabetes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936835     DOI: 10.1023/a:1017980713089

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses.

Authors:  P S Padayatti; A S Ng; K Uchida; M A Glomb; R H Nagaraj
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

2.  [The role of glycation in cataract lens in diabetic patients].

Authors:  H Hashimoto
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1998-01

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Role of glycosylation in protein disulfide formation and cataractogenesis.

Authors:  N H Ansari; Y C Awasthi; S K Srivastava
Journal:  Exp Eye Res       Date:  1980-07       Impact factor: 3.467

Review 5.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

6.  Conformational changes induced in lens alpha- and gamma-crystallins by modification with glucose 6-phosphate. Implications for cataract.

Authors:  H T Beswick; J J Harding
Journal:  Biochem J       Date:  1987-09-15       Impact factor: 3.857

7.  Progressive changes in lens crystallin glycation and high-molecular-weight aggregate formation leading to cataract development in streptozotocin-diabetic rats.

Authors:  R E Perry; M S Swamy; E C Abraham
Journal:  Exp Eye Res       Date:  1987-02       Impact factor: 3.467

8.  Diabetic cataract formation: potential role of glycosylation of lens crystallins.

Authors:  V J Stevens; C A Rouzer; V M Monnier; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

9.  Non-enzymatic glycosylation in human diabetic lens crystallins.

Authors:  J N Liang; L L Hershorin; L T Chylack
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

10.  Nonenzymatic glycosylation of bovine lens crystallins. Effect of aging.

Authors:  S H Chiou; L T Chylack; W H Tung; H F Bunn
Journal:  J Biol Chem       Date:  1981-05-25       Impact factor: 5.157

View more
  13 in total

1.  Effect of methylglyoxal modification of human α-crystallin on the structure, stability and chaperone function.

Authors:  S Mukhopadhyay; M Kar; K P Das
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

2.  Reduction of experimental diabetic vascular leakage and pericyte apoptosis in mice by delivery of αA-crystallin with a recombinant adenovirus.

Authors:  Y H Kim; S Y Park; J Park; Y S Kim; E M Hwang; J Y Park; G S Roh; H J Kim; S S Kang; G J Cho; W S Choi
Journal:  Diabetologia       Date:  2012-07-08       Impact factor: 10.122

3.  Role of the specifically targeted lysine residues in the glycation dependent loss of chaperone activity of alpha A- and alpha B-crystallins.

Authors:  Edathara C Abraham; Jin Huaqian; Atya Aziz; Anbarasu Kumarasamy; Poppy Datta
Journal:  Mol Cell Biochem       Date:  2007-12-25       Impact factor: 3.396

4.  Glycation by ascorbic acid oxidation products leads to the aggregation of lens proteins.

Authors:  Mikhail Linetsky; Ekaterina Shipova; Rongzhu Cheng; Beryl J Ortwerth
Journal:  Biochim Biophys Acta       Date:  2007-10-16

5.  Reversal of chaperone activity loss of glycated alphaA-crystallin by a crosslink breaker.

Authors:  Poppy Datta; Latha Kallur; Edathara C Abraham
Journal:  Mol Cell Biochem       Date:  2008-06-03       Impact factor: 3.396

6.  Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays.

Authors:  M Satish Kumar; P Yadagiri Reddy; P Anil Kumar; Ira Surolia; G Bhanuprakash Reddy
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

Review 7.  Role of calpains in diabetes mellitus-induced cataractogenesis: a mini review.

Authors:  Suman Biswas; Frederick Harris; Jaipaul Singh; David Phoenix
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

8.  Effect of glycation on alpha-crystallin structure and chaperone-like function.

Authors:  P Anil Kumar; M Satish Kumar; G Bhanuprakash Reddy
Journal:  Biochem J       Date:  2007-12-01       Impact factor: 3.857

Review 9.  Lens aging: effects of crystallins.

Authors:  K Krishna Sharma; Puttur Santhoshkumar
Journal:  Biochim Biophys Acta       Date:  2009-05-20

10.  FoxO3a Serves as a Biomarker of Oxidative Stress in Human Lens Epithelial Cells under Conditions of Hyperglycemia.

Authors:  Ilangovan Raju; Krishnaswamy Kannan; Edathara C Abraham
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.